Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Roche's Kadcyla fails in gastric cancer trial

Roche's Kadcyla fails in gastric cancer trial Kadcyla (trastuzumab emtansine) - an antibody-drug conjugate (ADC) that links the antibody in Roche's Herceptin to a cytotoxic molecule - was unable to show a benefit as a second-line treatment ... The trial is particularly disappointing as Kadcyla

Indian court blocks generic of Merck's Januvia

Indian court blocks generic of Merck's Januvia Gilead's Sovaldi (sofosbuvir) and Roche's Herceptin (trastuzumab), amongst others.

Roche's Perjeta launches in UK for early breast cancer

Roche's Perjeta launches in UK for early breast cancer The same indication was approved in the US in 2013. Perjeta is a HER2 dimerisation inhibitor that works via a different mechanism to Roche's other HER2-targeting drug Herceptin (trastuzumab) ... Perjeta is well on course to achieve blockbuster sales and -

Amgen and Allergan close on Avastin biosimilar filing

Amgen and Allergan close on Avastin biosimilar filing the year, fractionally behind breast cancer drug Herceptin (trastuzumab). ... Meanwhile, biosimilars of other mAbs - including Herceptin, Humira, Amgen's arthritis drug Enbrel (etanercept) and Novartis/Roche's eye therapy Lucentis (ranibizumab) - have

First Merck/Samsung biosimilar cleared in South Korea

First Merck/Samsung biosimilar cleared in South Korea s breast cancer therapy Herceptin (trastuzumab) in late-stage clinical development.

[ Previous 5 results ] 12 13 14 15 16 17 18 19 20 21 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics